Skip to main content
William Sikov, MD, Oncology, Providence, RI

WilliamSikovMD

Oncology Providence, RI

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology

Associate Professor of Medicine, Brown University

Dr. Sikov is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sikov's full profile

Already have an account?

  • Office

    1 Blackstone Street
    2ND floor
    Providence, RI 02903
    Phone+1 401-453-7520
    Fax+1 401-453-7785

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1982 - 1985
  • Yale School of Medicine
    Yale School of MedicineClass of 1982

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 1989 - 2026
  • MA State Medical License
    MA State Medical License 1986 - 2025
  • PA State Medical License
    PA State Medical License 1983 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Immunophenotype with Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer  
    Charles E Geyer, William M Sikov, JAMA Oncology

Lectures

  • CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TN... 
    2019 ASCO Annual Meeting - 6/1/2019

Other

Press Mentions

  • Women & Infants Doctor to Appear on ‘Jeopardy!’
    Women & Infants Doctor to Appear on ‘Jeopardy!’September 26th, 2019
  • Adjuvant Pertuzumab in HER2-Positive Breast Cancer: Value yet to Be Demonstrated
    Adjuvant Pertuzumab in HER2-Positive Breast Cancer: Value yet to Be DemonstratedOctober 10th, 2017
  • Pathologic Complete Response Best Predictor in Triple-Negative Prognosis
    Pathologic Complete Response Best Predictor in Triple-Negative PrognosisFebruary 10th, 2016
  • Join now to see all

Professional Memberships